| ΔR2* | T2* relaxation rate change |
| [18F]FDG | 2-Deoxy-2-[fluorine-18]-fluoro-d-glucose |
| α-SMA | α-smooth muscle actin |
| AI | Artificial intelligence |
| AuNP | Gold nanoparticle |
| BDL | Bile duct ligation |
| CAF | Cancer-associated fibroblast |
| CCL2 | C-C motif chemokine ligand 2 |
| CCl4 | Carbon tetrachloride |
| CCR2 | C-C motif chemokine receptor 2 |
| CDAHFD | Choline-deficient, L-amino acid-defined, high-fat diet |
| CKD | Chronic kidney disease |
| CMR | Cardiac magnetic resonance |
| CT | Computed tomography |
| CT-FMT | Hybrid computed tomography–fluorescence molecular tomography |
| COPD | Chronic obstructive pulmonary disease |
| CXCR4 | CXC-motif receptor 4 |
| DPP | Dipeptidyl peptidase |
| ECL1 | Extracellular loop one |
| ECM | Extracellular matrix |
| EMT | Epithelial–mesenchymal transition |
| EndMT | Endothelial–mesenchymal transition |
| FAP | Fibroblast activation protein |
| FAPI | Fibroblast activation protein inhibition |
| FDA | Food and Drug Administration |
| fILD | Fibrotic interstitial lung diseases |
| FITC | Fluorescein isothiocyanate |
| Gd | Gadolinium |
| GF | Growth factor |
| GPVI | Glycoprotein VI |
| HRCT | High-resolution computed tomography |
| HSC | Hepatic stellate cell |
| LC | Lung cancer |
| LDBVL | Low-dose bleomycin vascular leak |
| LGE | Late gadolinium enhancement |
| LIFU | Low-intensity focused ultrasound |
| IL-13 | Interleukin 13 |
| LOX | Lysyl oxidase |
| LOXL | Lysyl oxidase-like protein |
| IPF | Idiopathic pulmonary fibrosis |
| MAGL | Monoacylglycerol lipase |
| MCT | Monocrotaline |
| MI | Myocardial infarction |
| MMP | Matrix metalloproteinase |
| MRI | Magnetic resonance imaging |
| NASH | Non-alcoholic steatohepatitis |
| NIRF | Near-infrared fluorescence |
| PDGF | Platelet-derived growth factor |
| PET | Positron emission tomography |
| PFD | Antifibrotic pirfenidone |
| RGD | Arginine-glycine-aspartic |
| SLE | Systemic lupus erythematosus |
| SPECT | Single-photon emission computed tomography |
| SSc | Systemic sclerosis |
| SSTR | Somatostatin receptor |
| SUV | Standardized uptake values |
| TAA | Thioacetamide |
| TBR | Target-to-background ratio |
| TGF-β | Transforming growth factor beta |
| USPIO | Ultrasmall superparamagnetic iron oxide nanoparticle |
| UTE | Ultrashort echo time |
| VT | Volume of distribution |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| VLA-4 | Very late antigen-4 |